Nuvalent Highlights Pipeline Progress and Reports Second Quarter 2023 Financial Results
/PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically...
United Kingdom James Porter Prnewswire Nuvalent Inc Nuvalent Inc Exchange Commission Company Annual Report On Form
Source: prnewswire.com